Cargando…

Foxp3(+) T reg cells control psoriasiform inflammation by restraining an IFN-I–driven CD8(+) T cell response

Psoriasis is a complex inflammatory skin disease affecting ∼3% of the population worldwide. Although type I interferons (IFN-I) are thought to be involved in its pathogenesis, the details of this relationship remain elusive. Here we show that in a murine model of imiquimod-driven psoriatic skin infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockenhuber, Krista, Hegazy, Ahmed N., West, Nathaniel R., Ilott, Nicholas E., Stockenhuber, Alexander, Bullers, Samuel J., Thornton, Emily E., Arnold, Isabelle C., Tucci, Andrea, Waldmann, Herman, Ogg, Graham S., Powrie, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080913/
https://www.ncbi.nlm.nih.gov/pubmed/29980582
http://dx.doi.org/10.1084/jem.20172094
Descripción
Sumario:Psoriasis is a complex inflammatory skin disease affecting ∼3% of the population worldwide. Although type I interferons (IFN-I) are thought to be involved in its pathogenesis, the details of this relationship remain elusive. Here we show that in a murine model of imiquimod-driven psoriatic skin inflammation, Foxp3(+) regulatory T cells (T reg cells) control inflammation severity by restraining IFN-I. Depletion of T reg cells induces IFN-I and IFN-stimulated gene expression, and leads to accumulation of CD8(+) T cells in lesional skin. Mononuclear phagocytes (MNPs) were the source of IFN-I, and their depletion reversed the effect of T reg cell depletion. Blockade of IFN-I signaling abolished CD8(+) T cell infiltration and excess inflammation in the skin of T reg cell–depleted mice. Depletion of CD8(+) T cells attenuated pathology, confirming their role as critical effector cells downstream of IFN-I. Our results describe an unexpected role for T reg cells in restraint of an MNP–IFN-I–driven CD8(+) T cell response during psoriasiform skin inflammation. These findings highlight a pathway with potential relevance for the treatment of early-stage disease.